Li Wang

机构：Anhui Medical University, Nanjing General Hospital of Nanjing Military Command, Bozhou People's Hospital, State Key Laboratory of Chemical Engineering, Nanjing University · ORCID：0000-0003-4337-3547

发表论文 54 篇 · 总被引 2088 次 · h-index 23

代表论文

• Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE/TFAM signaling in diabetic kidney disease (2023 · Free Radical Biology and Medicine · 被引 104)
• Social support, psychological capital, multidimensional job burnout, and turnover intention of primary medical staff: a path analysis drawing on conservation of resources theory (2024 · Human Resources for Health · 被引 67)
• Current status and related factors of turnover intention of primary medical staff in Anhui Province, China: a cross-sectional study (2021 · Human Resources for Health · 被引 42)
• Developing a novel strategy for COPD therapy by targeting Nrf2 and metabolism reprogramming simultaneously (2021 · Free Radical Biology and Medicine · 被引 29)
• TRIM32 Inhibition Attenuates Apoptosis, Oxidative Stress, and Inflammatory Injury in Podocytes Induced by High Glucose by Modulating the Akt/GSK-3β/Nrf2 Pathway (2021 · Inflammation · 被引 27)
• Astragaloside IV attenuates high glucose‐induced NF‐κB ‐mediated inflammation through activation of PI3K / AKT‐ERK ‐dependent Nrf2/ ARE signaling pathway in glomerular mesangial cells (2023 · Phytotherapy Research · 被引 25)